Brazilian OTC marketing potential for U.S. companies stressed by consultants.
This article was originally published in The Tan Sheet
Executive Summary
BRAZILIAN OTC MARKET OPPORTUNITIES ABOUND FOR U.S. COMPANIES due to the country's growing buying power and population, U.S. firms' marketing experience and the proximity of the region, IMS SelfMedication Europe VP William Quaeyhaegens declared at the Nonprescription Drug Manufacturers Association's annual conference in Palm Beach, Fla. March 19-22. U.S. companies hold a 25% share of the OTC market in Brazil, an amount that could easily be higher, Quaeyhaegens said. The session on the Brazilian OTC market was sponsored by NDMA's International Affairs Committee.